Skip to content

Insider · CIK 0001994255

Xu Chen

officerdirectorpresident

Files at BZ (Kanzhun Ltd). First filing Jun 17, 2026, latest Sep 11, 2026.

Xu Chen files SEC Form 4 as director and president at BZ (Kanzhun Ltd). Since Jun 17, 2026, Xu Chen has reported 0 open-market buys worth $0 and 3 open-market sells worth $5.0M, the latest filed on Sep 11, 2026.

A track record needs three past buys with six months of prices behind them; Xu Chen has 0, so none is measured yet.

The newest scored trade: sold $1.6M of BZ on Sep 10, 2026, filed Sep 11, 2026, scored 60 (notable). In the last 12 months: 0 buys worth $0 and 3 sells worth $5.0M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $5.0M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BZ: Kanzhun Ltd

BZOct 9, 2026 · close 15.73

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
60Notable
BZsell 3
Kanzhun Ltd
$1.6M
200,000 shares
-57%-
60Notable
BZsell 3
Kanzhun Ltd
$3.4M
400,000 shares
-72%-
20Weak
BZsell 3
Kanzhun Ltd
$573
84 shares
-0%+1% from low-47% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Dec 4, 2025 BZ
Kanzhun Ltd
27,000
0.00% of outstanding
$584kDec 4, 2025none
Dec 17, 2024 BZ
Kanzhun Ltd
28,000
0.00% of outstanding
$387kDec 17, 2024none

Transactions

Every row this insider has filed, 12 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 10, 2026BZ
Kanzhun Ltd
MOption exercise
Class A ordinary shares
+200,000$0.50$100k353,34032 d ago
Sep 10, 2026BZ
Kanzhun Ltd
SOpen-market sale
Class A ordinary shares
-200,000$8.15$1.6M153,34032 d ago
Sep 10, 2026BZ
Kanzhun Ltd
MOption exercise
Option (Right to Buy)derivative
-200,000$0.00$0709,00032 d ago
Sep 4, 2026BZ
Kanzhun Ltd
MOption exercise
Class A ordinary shares
+400,000$0.50$200k553,34034 d ago
Sep 4, 2026BZ
Kanzhun Ltd
SOpen-market sale
Class A ordinary shares
-400,000$8.50$3.4M153,34034 d ago
Sep 4, 2026BZ
Kanzhun Ltd
MOption exercise
Option (Right to Buy)derivative
-400,000$0.00$0909,00034 d ago
Jun 16, 2026BZ
Kanzhun Ltd
MOption exercise
Class A ordinary shares
+370--153,424Jun 17, 2026
Jun 16, 2026BZ
Kanzhun Ltd
SOpen-market sale
Class A ordinary shares
-84$6.83$573153,340Jun 17, 2026
Jun 15, 2026BZ
Kanzhun Ltd
AGrant or award
Restricted Share Unitderivative
+932,434$0.00$0932,434Jun 17, 2026
Jun 16, 2026BZ
Kanzhun Ltd
MOption exercise
Restricted Share Unitderivative
-370$0.00$00Jun 17, 2026
Mar 20, 2026BZ
Kanzhun Ltd
MOption exercise
Class A ordinary shares
+4,702--153,054Mar 24, 2026
Mar 20, 2026BZ
Kanzhun Ltd
MOption exercise
Restricted Share Unitderivative
-4,702$0.00$00Mar 24, 2026

Questions about Xu Chen

Answered from the filings on this page, as of the latest one.

Is Xu Chen buying or selling?

In the last 12 months Xu Chen reported 0 open-market buys worth $0 and 3 open-market sells worth $5.0M on SEC Form 4; the latest was sold $1.6M of BZ on Sep 10, 2026. Grants, option exercises and tax withholding are not counted.

How did Xu Chen's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Xu Chen has 0.

Where does Xu Chen file Form 4?

Xu Chen has filed Form 4 at BZ (Kanzhun Ltd) as President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.